{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,8]],"date-time":"2025-11-08T14:12:28Z","timestamp":1762611148467,"version":"build-2065373602"},"reference-count":43,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,6,30]],"date-time":"2025-06-30T00:00:00Z","timestamp":1751241600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100011110","name":"UCB","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100011110","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100002429","name":"Amgen Inc","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100002429","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Orthopaedic Translation"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1016\/j.jot.2025.06.019","type":"journal-article","created":{"date-parts":[[2025,7,15]],"date-time":"2025-07-15T14:15:10Z","timestamp":1752588910000},"page":"1-7","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["High-dose romosozumab promoted bone regeneration of critical-size ulnar defect filled with demineralized bone matrix in nonhuman primates"],"prefix":"10.1016","volume":"54","author":[{"given":"Xiaodong","family":"Li","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2684-3244","authenticated-orcid":false,"given":"Frank","family":"Asuncion","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Ominsky","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qing-Tian","family":"Niu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3024-2804","authenticated-orcid":false,"given":"Kristina E.","family":"Akesson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeffrey","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jay","family":"Lieberman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2883-9134","authenticated-orcid":false,"given":"Hua Zhu","family":"Ke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"7","key":"10.1016\/j.jot.2025.06.019_bib1","doi-asserted-by":"crossref","first-page":"879","DOI":"10.3390\/ph15070879","article-title":"Bone tissue engineering in the treatment of bone defects","volume":"15","author":"Xue","year":"2022","journal-title":"Pharmaceuticals"},{"issue":"3","key":"10.1016\/j.jot.2025.06.019_bib2","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1007\/s00590-017-2063-0","article-title":"Treatment of critical-sized bone defects: clinical and tissue engineering perspectives","volume":"28","author":"Roddy","year":"2018","journal-title":"Eur J Orthop Surg Traumatol"},{"issue":"6","key":"10.1016\/j.jot.2025.06.019_bib3","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1186\/ar4053","article-title":"Biologic adjuvants for fracture healing","volume":"14","author":"Virk","year":"2012","journal-title":"Arthritis Res Ther"},{"issue":"2","key":"10.1016\/j.jot.2025.06.019_bib4","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1002\/jor.22498","article-title":"Evaluation of the effects of systemic treatment with a sclerostin neutralizing antibody on bone repair in a rat femoral defect model","volume":"32","author":"Alaee","year":"2014","journal-title":"J Orthop Res"},{"issue":"8","key":"10.1016\/j.jot.2025.06.019_bib5","doi-asserted-by":"crossref","first-page":"694","DOI":"10.2106\/JBJS.L.00285","article-title":"Systemic administration of sclerostin antibody enhances bone repair in a critical-sized femoral defect in a rat model","volume":"95","author":"Virk","year":"2013","journal-title":"J Bone Joint Surg Am"},{"issue":"1","key":"10.1016\/j.jot.2025.06.019_bib6","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1002\/jbmr.173","article-title":"Single-dose, placebo-controlled, randomized study of AMG 785, a sclerostin monoclonal antibody","volume":"26","author":"Padhi","year":"2011","journal-title":"J Bone Miner Res"},{"issue":"5","key":"10.1016\/j.jot.2025.06.019_bib7","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1056\/NEJMoa1305224","article-title":"Romosozumab in postmenopausal women with low bone mineral density","volume":"370","author":"McClung","year":"2014","journal-title":"N Engl J Med"},{"issue":"16","key":"10.1016\/j.jot.2025.06.019_bib8","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1056\/NEJMoa1607948","article-title":"Romosozumab treatment in postmenopausal women with osteoporosis","volume":"375","author":"Cosman","year":"2016","journal-title":"N Engl J Med"},{"issue":"15","key":"10.1016\/j.jot.2025.06.019_bib9","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1056\/NEJMoa1708322","article-title":"Romosozumab or alendronate for fracture prevention in women with osteoporosis","volume":"377","author":"Saag","year":"2017","journal-title":"N Engl J Med"},{"issue":"10102","key":"10.1016\/j.jot.2025.06.019_bib10","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.1016\/S0140-6736(17)31613-6","article-title":"Romosozumab (sclerostin monoclonal antibody) versus teriparatide in postmenopausal women with osteoporosis transitioning from oral bisphosphonate therapy: a randomised, open-label, phase 3 trial","volume":"390","author":"Langdahl","year":"2017","journal-title":"Lancet"},{"issue":"5","key":"10.1016\/j.jot.2025.06.019_bib11","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1007\/s11999-015-4669-z","article-title":"Does teriparatide improve femoral neck fracture healing: results from a randomized placebo-controlled trial","volume":"474","author":"Bhandari","year":"2016","journal-title":"Clin Orthop Relat Res"},{"issue":"22","key":"10.1016\/j.jot.2025.06.019_bib12","doi-asserted-by":"crossref","first-page":"1868","DOI":"10.2106\/JBJS.15.01217","article-title":"Effects of teriparatide compared with risedronate on recovery after pertrochanteric hip fracture: results of a randomized, active-controlled, double-blind clinical trial at 26 weeks","volume":"98","author":"Aspenberg","year":"2016","journal-title":"J Bone Joint Surg Am"},{"issue":"16","key":"10.1016\/j.jot.2025.06.019_bib13","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.2106\/JBJS.19.01008","article-title":"Romosozumab in skeletally mature adults with a fresh unilateral tibial diaphyseal fracture: a randomized phase-2 study","volume":"102","author":"Bhandari","year":"2020","journal-title":"J Bone Joint Surg Am"},{"issue":"8","key":"10.1016\/j.jot.2025.06.019_bib14","doi-asserted-by":"crossref","first-page":"693","DOI":"10.2106\/JBJS.19.00790","article-title":"A randomized, placebo-controlled study of romosozumab for the treatment of hip fractures","volume":"102","author":"Schemitsch","year":"2020","journal-title":"J Bone Joint Surg Am"},{"issue":"2","key":"10.1016\/j.jot.2025.06.019_bib15","doi-asserted-by":"crossref","first-page":"129","DOI":"10.5435\/00124635-200503000-00006","article-title":"Use of osteopromotive growth factors, demineralized bone matrix, and ceramics to enhance spinal fusion","volume":"13","author":"Khan","year":"2005","journal-title":"J Am Acad Orthop Surg"},{"issue":"6","key":"10.1016\/j.jot.2025.06.019_bib16","doi-asserted-by":"crossref","first-page":"1424","DOI":"10.1002\/jbmr.2152","article-title":"Tissue-level mechanisms responsible for the increase in bone formation and bone volume by sclerostin antibody","volume":"29","author":"Ominsky","year":"2014","journal-title":"J Bone Miner Res"},{"issue":"4","key":"10.1016\/j.jot.2025.06.019_bib17","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1002\/jbmr.3036","article-title":"Romosozumab improves bone mass and strength while maintaining bone quality in ovariectomized cynomolgus monkeys","volume":"32","author":"Ominsky","year":"2017","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.jot.2025.06.019_bib18","doi-asserted-by":"crossref","DOI":"10.1016\/j.yrtph.2020.104697","article-title":"Nonclinical cardiovascular safety evaluation of romosozumab, an inhibitor of sclerostin for the treatment of osteoporosis in postmenopausal women at high risk of fracture","volume":"115","author":"Turk","year":"2020","journal-title":"Regul Toxicol Pharmacol"},{"key":"10.1016\/j.jot.2025.06.019_bib19","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.bone.2017.04.005","article-title":"Kinetic reconstruction reveals time-dependent effects of romosozumab on bone formation and osteoblast function in vertebral cancellous and cortical bone in cynomolgus monkeys","volume":"101","author":"Boyce","year":"2017","journal-title":"Bone"},{"issue":"6","key":"10.1016\/j.jot.2025.06.019_bib20","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1016\/j.injury.2011.03.031","article-title":"The biology of fracture healing","volume":"42","author":"Marsell","year":"2011","journal-title":"Injury"},{"issue":"22","key":"10.1016\/j.jot.2025.06.019_bib21","doi-asserted-by":"crossref","first-page":"1852","DOI":"10.2106\/JBJS.O.00171","article-title":"Systemic administration of sclerostin antibody enhances bone morphogenetic protein-induced femoral defect repair in a rat model","volume":"97","author":"Tinsley","year":"2015","journal-title":"J Bone Joint Surg Am"},{"key":"10.1016\/j.jot.2025.06.019_bib22","article-title":"Successful treatment of humeral shaft nonunion with romosozumab: a case report","volume":"37","author":"Lee","year":"2022","journal-title":"Trauma Case Rep"},{"issue":"2","key":"10.1016\/j.jot.2025.06.019_bib23","doi-asserted-by":"crossref","first-page":"526","DOI":"10.52312\/jdrs.2021.82661","article-title":"Bone healing of distal radius nonunion treated with bridge plating with bone graft substitutes in combination with systemic romosozumab administration: a case report","volume":"32","author":"Uemura","year":"2021","journal-title":"Jt Dis Relat Surg"},{"issue":"4","key":"10.1016\/j.jot.2025.06.019_bib24","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1359\/jbmr.081206","article-title":"Sclerostin antibody treatment increases bone formation, bone mass, and bone strength in a rat model of postmenopausal osteoporosis","volume":"24","author":"Li","year":"2009","journal-title":"J Bone Miner Res"},{"issue":"5","key":"10.1016\/j.jot.2025.06.019_bib25","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1002\/jbmr.3038","article-title":"Sclerostin antibody administration converts bone lining cells into active osteoblasts","volume":"32","author":"Kim","year":"2017","journal-title":"J Bone Miner Res"},{"issue":"1","key":"10.1016\/j.jot.2025.06.019_bib26","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1002\/jbmr.4457","article-title":"Modeling-based bone formation after 2 months of romosozumab treatment: results from the FRAME clinical trial","volume":"37","author":"Eriksen","year":"2022","journal-title":"J Bone Miner Res"},{"issue":"6","key":"10.1016\/j.jot.2025.06.019_bib27","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1016\/j.bone.2007.01.015","article-title":"Human parathyroid hormone (1-34) accelerates natural fracture healing process in the femoral osteotomy model of cynomolgus monkeys","volume":"40","author":"Manabe","year":"2007","journal-title":"Bone"},{"issue":"5","key":"10.1016\/j.jot.2025.06.019_bib28","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1002\/jbmr.307","article-title":"Inhibition of sclerostin by monoclonal antibody enhances bone healing and improves bone density and strength of nonfractured bones","volume":"26","author":"Ominsky","year":"2011","journal-title":"J Bone Miner Res"},{"issue":"15","key":"10.1016\/j.jot.2025.06.019_bib29","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.2106\/JBJS.22.01092","article-title":"Dual inhibition of the Wnt inhibitors DKK1 and sclerostin promotes fracture healing and increases the density and strength of uninjured bone: an experimental study in nonhuman primates","volume":"105","author":"Florio","year":"2023","journal-title":"J Bone Joint Surg Am"},{"issue":"2","key":"10.1016\/j.jot.2025.06.019_bib30","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1007\/s11914-022-00770-7","article-title":"Clinical assessments of fracture healing and basic science correlates: is there room for convergence?","volume":"21","author":"Lopas","year":"2023","journal-title":"Curr Osteoporos Rep"},{"key":"10.1016\/j.jot.2025.06.019_bib31","doi-asserted-by":"crossref","unstructured":"Lane J, Langdahl B, Stone M, Kurth A, Oates M, Timoshanko J, et al. Romosozumab in patients who experienced an on-study fracture: post hoc analyses of the FRAME and ARCH phase 3 trials. Osteoporos Int;35(7):1195-1204.","DOI":"10.1007\/s00198-024-07049-w"},{"issue":"3","key":"10.1016\/j.jot.2025.06.019_bib32","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1001\/jama.285.3.320","article-title":"Risk of new vertebral fracture in the year following a fracture","volume":"285","author":"Lindsay","year":"2001","journal-title":"JAMA"},{"issue":"3","key":"10.1016\/j.jot.2025.06.019_bib33","doi-asserted-by":"crossref","first-page":"226","DOI":"10.4103\/0019-5413.80040","article-title":"Repair of long bone defects with demineralized bone matrix and autogenous bone composite","volume":"45","author":"Ozdemir","year":"2011","journal-title":"Indian J Orthop"},{"issue":"4","key":"10.1016\/j.jot.2025.06.019_bib34","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1097\/01.BRS.0000090823.12652.F9","article-title":"Evidence of osteoinduction by Grafton demineralized bone matrix in nonhuman primate spinal fusion","volume":"29","author":"Louis-Ugbo","year":"2004","journal-title":"Spine"},{"issue":"10","key":"10.1016\/j.jot.2025.06.019_bib35","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1359\/jbmr.090411","article-title":"Sclerostin mediates bone response to mechanical unloading through antagonizing Wnt\/beta-catenin signaling","volume":"24","author":"Lin","year":"2009","journal-title":"J Bone Miner Res"},{"issue":"2","key":"10.1016\/j.jot.2025.06.019_bib36","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.bone.2010.09.009","article-title":"Sclerostin antibody increases bone mass by stimulating bone formation and inhibiting bone resorption in a hindlimb-immobilization rat model","volume":"48","author":"Tian","year":"2011","journal-title":"Bone"},{"issue":"11","key":"10.1016\/j.jot.2025.06.019_bib37","doi-asserted-by":"crossref","first-page":"1994","DOI":"10.1002\/jbmr.2549","article-title":"Sclerostin antibody preserves the morphology and structure of osteocytes and blocks the severe skeletal deterioration after motor-complete spinal cord injury in rats","volume":"30","author":"Qin","year":"2015","journal-title":"J Bone Miner Res"},{"issue":"4","key":"10.1016\/j.jot.2025.06.019_bib38","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1002\/jbmr.2396","article-title":"Sclerostin inhibition prevents spinal cord injury-induced cancellous bone loss","volume":"30","author":"Beggs","year":"2015","journal-title":"J Bone Miner Res"},{"issue":"4","key":"10.1016\/j.jot.2025.06.019_bib39","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1007\/s00223-018-0439-8","article-title":"Sclerostin antibody reverses the severe sublesional bone loss in rats after chronic spinal cord injury","volume":"103","author":"Zhao","year":"2018","journal-title":"Calcif Tissue Int"},{"key":"10.1016\/j.jot.2025.06.019_bib40","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.bone.2016.02.005","article-title":"Sclerostin antibody prevented progressive bone loss in combined ovariectomized and concurrent functional disuse","volume":"87","author":"Zhang","year":"2016","journal-title":"Bone"},{"issue":"S2","key":"10.1016\/j.jot.2025.06.019_bib41","first-page":"1545","article-title":"Treatment with monthly romosozumab injections increases areal bone mineral density at the lumbar spine and hip in women with chronic spinal cord injury","volume":"38","author":"Edwards","year":"2023","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.jot.2025.06.019_bib42","doi-asserted-by":"crossref","DOI":"10.1210\/jendso\/bvae163.358","article-title":"Assessing the efficacy and safety of setrusumab for osteogenesis imperfecta: updated phase 2 data from the phase 2\/3 orbit study","volume":"8","author":"Gottesman","year":"2024","journal-title":"J Endocr Soc"},{"key":"10.1016\/j.jot.2025.06.019_bib43","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.jot.2024.06.013","article-title":"Localized delivery of metformin via 3D printed GelMA-Nanoclay hydrogel scaffold for enhanced treatment of diabetic bone defects","volume":"47","author":"Li","year":"2024","journal-title":"J Orthop Translat"}],"container-title":["Journal of Orthopaedic Translation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2214031X25001123?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2214031X25001123?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,8]],"date-time":"2025-11-08T14:08:37Z","timestamp":1762610917000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2214031X25001123"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9]]},"references-count":43,"alternative-id":["S2214031X25001123"],"URL":"https:\/\/doi.org\/10.1016\/j.jot.2025.06.019","relation":{},"ISSN":["2214-031X"],"issn-type":[{"type":"print","value":"2214-031X"}],"subject":[],"published":{"date-parts":[[2025,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"High-dose romosozumab promoted bone regeneration of critical-size ulnar defect filled with demineralized bone matrix in nonhuman primates","name":"articletitle","label":"Article Title"},{"value":"Journal of Orthopaedic Translation","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jot.2025.06.019","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier B.V. on behalf of Chinese Speaking Orthopaedic Society.","name":"copyright","label":"Copyright"}]}}